GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Captor Therapeutics CTX.WA · PLN

N/A · GPW · 🇵🇱 Poland

Compare

53.60

-0.74%

Close of 9 Nov 2026, in PLN

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in PLN, from our data supplier.

FY2025

Revenue

PLN 4.7m

FY2017FY2025

Net income

−PLN 42.0m

FY2017FY2025

Free cash flow

−PLN 36.5m

FY2017FY2025

Shareholders' equity

PLN 23.5m

FY2017FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
RevenuePLN 4.7mPLN 15.8mPLN 13.2mPLN 9.2mPLN 4.0mPLN 1.5m—PLN 16,000PLN 474,000
Research and developmentPLN 42.9mPLN 34.7mPLN 64.8mPLN 44.2mPLN 23.1mPLN 23.6mPLN 19.2mPLN 10.7mPLN 2.5m
Operating income−PLN 53.2m−PLN 44.8m−PLN 73.0m−PLN 38.4m−PLN 31.8m−PLN 12.3m−PLN 7.9m−PLN 4.2m−PLN 133,000
Net income−PLN 42.0m−PLN 38.4m−PLN 70.6m−PLN 35.9m−PLN 32.6m−PLN 13.1m−PLN 8.7m−PLN 4.4m−PLN 180,000
Diluted earnings per share-7.60-6.99-15.19-8.61-7.89-4.03-1.44-0.73-0.03

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assetsPLN 40.0mPLN 87.5mPLN 97.3mPLN 113.0mPLN 143.5mPLN 25.8mPLN 25.3mPLN 18.1mPLN 5.1m
Cash and short-term investmentsPLN 32.1mPLN 39.3mPLN 75.7mPLN 90.9mPLN 117.9mPLN 10.7mPLN 12.3mPLN 2.4mPLN 1.6m
Total liabilitiesPLN 16.5mPLN 23.0mPLN 28.1mPLN 16.7mPLN 19.3mPLN 26.8mPLN 21.0mPLN 14.6mPLN 5.0m
DebtPLN 3.6mPLN 5.6mPLN 3.8mPLN 7.0mPLN 8.2mPLN 12.4mPLN 10.3mPLN 10.9mPLN 2.8m
Shareholders' equityPLN 23.5mPLN 64.5mPLN 69.2mPLN 96.3mPLN 124.2m−PLN 1.0mPLN 4.3mPLN 3.4mPLN 144,000
Shares outstanding6m5m5m4m4m3m6m6m6m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations−PLN 36.3m−PLN 31.9m−PLN 52.2m−PLN 22.9m−PLN 28.5m−PLN 595,000PLN 4.4m−PLN 2.1mPLN 2.1m
Capital spending−PLN 210,000−PLN 424,000−PLN 3.0m−PLN 892,000−PLN 5.1m−PLN 212,000−PLN 229,000−PLN 100,000—
Free cash flow−PLN 36.5m−PLN 32.3m−PLN 55.2m−PLN 23.8m−PLN 33.6m−PLN 807,000PLN 4.2m−PLN 2.2mPLN 2.1m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenuePLN 1.6mPLN 328,000PLN 44,000—PLN 2.0mPLN 2.6mPLN 3.0mPLN 3.5m
Operating income−PLN 14.6m−PLN 12.2m−PLN 12.3m−PLN 11.8m−PLN 10.7m−PLN 10.7m−PLN 11.0m−PLN 10.3m
Net income−PLN 11.4m−PLN 11.4m−PLN 10.0m−PLN 11.5m−PLN 9.8m−PLN 10.7m−PLN 8.8m−PLN 10.2m
Diluted earnings per share-1.87-1.87-1.82-2.08-1.76-1.94-1.59-1.86
Cash from operations−PLN 11.0m−PLN 12.0m−PLN 37.0m−PLN 11.0m−PLN 10.0mPLN 23.0m−PLN 8.0m−PLN 5.0m
Capital spending———————−PLN 6.0m
Free cash flow———————−PLN 11.0m
Total assetsPLN 79.5mPLN 26.1mPLN 40.0mPLN 44.5mPLN 55.1mPLN 74.1mPLN 87.5mPLN 64.6m
Cash and short-term investmentsPLN 71.5mPLN 17.9mPLN 32.1mPLN 36.0mPLN 48.7mPLN 61.4mPLN 39.3mPLN 48.8m
DebtPLN 2.1mPLN 2.1mPLN 2.1mPLN 1.8mPLN 839,000PLN 2.3mPLN 2.7mPLN 3.0m
Shareholders' equityPLN 65.1mPLN 12.1mPLN 23.5mPLN 33.3mPLN 44.8mPLN 54.1mPLN 64.5mPLN 41.1m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-20.2%26.2%—
Operating income11.5%34.0%—
Net income5.4%26.3%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021
Price to earnings-9.5-6.0-6.5-18.6-22.8
Price to sales85.414.734.872.8186.1

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.